I have a strong interest in using chemistry to solve pressing issues in animal and human health. My lab works towards making new molecular imaging and radiotherapy drugs that can be used to improve the detection, staging, and treatment of a variety of diseases such as cancer and severe bacterial infections. Radiochemistry is an exciting and powerful field of study, and I’m thrilled to be working at the University of Saskatchewan (U of S) with the new Fedoruk Centre for Nuclear Innovation and their Saskatchewan Centre for Cyclotron Sciences (SCCS), as well as the Canadian Light Source (CLS). I started my lab at the U of S in the Chemistry department (College of Arts and Sciences) in the summer of 2016, and have been awarded the position of Canada Research Chair in Radiochemistry.
- Assistant Professor of Chemistry, Canada Research Chair (CRC) in Radiochemistry, the University of Saskatchewan, Saskatoon, Canada, 07/2016 - present.
- Postdoctoral Fellow (Research Scholar): Radiochemistry, ligand design and synthesis, and Cancer research. With Dr. Jason S. Lewis at Memorial Sloan Kettering Cancer Center, New York, United States, 07/2014 – 06/2016.
- Doctorate in Chemistry (Ph.D.): Bioinorganic and Medicinal Chemistry with a focus on Radiochemistry. With Dr. Chris Orvig at the University of British Columbia, and Dr. Michael Adam at TRIUMF, Vancouver, Canada, dissertation title “Synthesis, Evaluation, and Application of New Ligands for Radiometal Based Radiopharmaceuticals”, 05/2009 – 04/2014.
- Bachelor of Science (Chemistry): Honours, co-op, with distinction, University of Victoria, Canada, 09/2003 - 04/2009.
- TRIUMF, research chemist, Life Science and Medicinal Chemistry Division, radiopharmaceuticals, Vancouver, BC, Canada, 05/2008 - 08/2008.
- University of Victoria, Dr. Matthew G. Moffitt, summer NSERC USRA research chemist, nano materials, Victoria, BC, Canada, 05/2007 - 08/2007.
- TRIUMF, research chemist, Life Science and Medicinal Chemistry Division, radiopharmaceuticals, Vancouver, BC, Canada, 09/2006 - 12/2006.
- AXYS Analytical, analytical chemist, Sidney, BC, Canada, 05/2006 - 08/2006.
- Dr. Brian M. Zeglis, Hunter College, New York, New York, USA. Dr. Price obtained a novel antibody from Quest PharmaTech in Edmonton, Alberta, which he is modifying to be a fluorescent and radioactive molecular imaging agent for ovarian and lung cancer. Dr. Price is collaborating with Dr. Zeglis to perform PET imaging experiments in murine models of ovarian and lung cancer (September 2016 – present).
- Dr. Chris Phenix, University of Saskatchewan, Saskatoon. Dr. Price is working closely with Dr. Phenix (Chemistry, U of S) to make new fluorescent and radioactive molecular imaging probes.